Reply to the Commentary: Should Injectable Meloxicam Be Approved for Use in Cats?

This publication has 19 references indexed in Scilit:

• Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
  Nature Reviews Nephrology, 2017
• Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed‐Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats
  CPT: Pharmacometrics & Systems Pharmacology, 2016
• Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney
  BMC Veterinary Research, 2015
• Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells
  Kidney International, 2011
• In vitroandex vivoinhibition of COX isoforms by robenacoxib in the cat: a comparative study
  Journal of Veterinary Pharmacology and Therapeutics, 2010
• Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib
  Journal of Veterinary Pharmacology and Therapeutics, 2009
• Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat
  British Journal of Pharmacology, 2005
• Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest
  Journal of Veterinary Pharmacology and Therapeutics, 2004
• Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
  Proceedings of the National Academy of Sciences, 1999
• Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat
  Research in Veterinary Science, 1996